BCL2 and metabolic dysfunction-associated steatotic liver disease: Bax and Bcl-2 are anti- and pro-apoptotic members, respectively, of the bcl-2 family [29] and higher Bax to Bcl-2 ratio is increased in the progression of non-alcoholic fatty liver disease with the manifestation of apoptosis [30].